Global Autologous Matrix-induced Chondrogenesis Market – Growth Focusing on Trends & Innovations during the Period Until 2024

Posted on 2018-05-14 by Mark Hub in Healthcare // 0 Comments

Albany, USA, 2018-May-14 — /EPR Network/ —In order to study the various trends and patterns prevailing in the overall market for Autologous Matrix-induced Chondrogenesis, Market Research Reports Search Engine (MRRSE) has included a new report titled “Autologous Matrix-induced Chondrogenesis Market” to its wide online database. This research assessment offers a clear insight about the influential factors that are expected to transform the global market in the near future. Readers can access the regional as well as segment-wise analysis for acquiring precise information about the global market structure.

Visit for Sample Report @ https://www.mrrse.com/sample/2495

The global autologous matrix-induced chondrogenesis (AMIC) market has been expected in a publication prepared by MRRSE to witness strategies aimed toward business expansion in developing economies. Countries such as South Africa, Mexico, China, India, and Brazil could be focused upon by AMIC players for gaining a strategic position in the market. This has been anticipated to help companies reduce their AMIC product costs supported by the hiring of cheap but skilled labor in emerging markets. Compounding a 47.0% share in the market in 2015, Smith & Nephew Plc., Zimmer Biomet Holdings, and Geistlich Pharma AG could be key AMIC players.

The analysts at MRRSE have foreseen the global AMIC market to rise at a CAGR of 8.6% between 2016 and 2024 to achieve a revenue valuation of US$186.38 mn by the concluding forecast year. In 2015, the market had reached a US$89.71 mn. By material, the AMIC market for collagen could attain a higher share of almost 50.0% by 2024. Calculated to develop at an 8.3% CAGR, North America has been predicted to be a highly productive market for AMIC.

In the next few years, the sale of AMIC products and materials could spike at a telling rate due to the surging demand for minimally invasive surgeries. Articular cartilage damage could be repaired with the biological treatment of AMIC which integrates microfracture surgery with bi-layer collagen I/III membrane application. The availability of this single-step procedure has allowed patients to have the alternative of opting for a minimally invasive procedure as a convenient solution to treat joint and bone disorders. The world AMIC market has been envisaged to receive a strong boost in its growth with the swelling pool of geriatric population easily vulnerable to such disorders.

Sports of various kinds have been witnessing a whole lot of participation in the recent time, which could increase further in future. This has been foretold to work in the favor of the world AMIC market as the number of sports injuries keeps elevating until the course of the forecast period.

Although the international AMIC market could embrace expansions in emerging countries, India, Australia, and Brazil have been envisioned to hinder its growth because of inefficient reimbursement systems. Patients could delay opting for AMIC procedures or products as most health insurance firms do not insure them. Besides this, there is a lack of sufficient clinical data that could advocate the long-term advantages or benefits of using AMIC.

Complete Report details with List of Tables and Figures @ https://www.mrrse.com/autologous-matrix-induced-chondrogenesis-market

Nevertheless, the demand for AMIC procedures and products has been prognosticated to be bolstered by the fast-progressing medical tourism sector. The rising collagen market could receive a strong momentum in growth due to a widespread application in tissue engineering. Dominating geographical markets such as North America accommodating an increasing pool of geriatrics have been projected to create opportunities in the international AMIC market.

The report also profiles major players in this market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Anika Therapeutics, Inc., Arthro-Kinetics, B. Braun Melsungen AG, BioTissue AG, CartiHeal, Geistlich Pharma AG, JRI Orthopaedics Ltd., Matricel GmbH, Smith & Nephew plc and Zimmer Biomet Holdings.

The global autologous matrix-induced chondrogenesis market has been segmented as follows:

Global Autologous Matrix-Induced Chondrogenesis Market, by Material

Hyaluronic Acid
Collagen
Polyethylene Glycol (PEG)
Poly lactic-co-glycolic acid (PGLA
Others

Global Autologous Matrix-Induced Chondrogenesis Market, by Geography

North America
- U.S.
- Canada
Europe
- U.K.
- Germany
- Rest of Europe
Asia Pacific
- China
- Japan
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa

Send an Inquiry @ https://www.mrrse.com/enquiry/2495

About Market Research Reports Search Engine (MRRSE)

Market Research Reports Search Engine (MRRSE) is an industry-leading database of Market Research Reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.

Matched content

Editor’s pick